COMPANYRESEARCH
Agenix has a very high risk, high return profile, but we believe the quality of TBV justifies a Speculative Buy rating.Download Research from Lodge Partners
FACTSHEET
Agenix is commercialising next generation drugs and diagnostics for major international markets creating an opportunity to improve the quality of life for millions of people worldwide.
Download the Agenix Fact Sheet →
 |
 |